Follicular NHL: from antibodies and vaccines to graft-versus-lymphoma effects.

@article{Maloney2007FollicularNF,
  title={Follicular NHL: from antibodies and vaccines to graft-versus-lymphoma effects.},
  author={David G Maloney},
  journal={Hematology. American Society of Hematology. Education Program},
  year={2007},
  pages={226-32}
}
  • David G Maloney
  • Published 2007 in
    Hematology. American Society of Hematology…
Monoclonal antibody therapy with rituximab in combination with standard chemotherapy has improved the survival of patients with advanced-stage follicular lymphoma (FL). A series of next-generation anti-CD20 antibodies may be less immunogenic and have even greater antitumor activity through augmented interactions with host effector mechanisms responsible for tumor cell kill. Additional approaches with patient-specific immunoglobulin idiotype vaccines; novel monoclonal antibodies binding to… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

Advanced-Stage III/IV Follicular Lymphoma

Strahlentherapie und Onkologie • 2010
View 1 Excerpt

Follicular non-Hodgkin's lymphoma.

Clinical radiology • 2010
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 37 references

Clinical activity of the immunoconjugate CMC-544 in B-cell malignancies: preliminary report of the expanded maximum tolerated dose (MTD) cohort of a phase 1 study [abstract

L Fayad, H Patel, G Verhoef
Blood • 2006
View 5 Excerpts
Highly Influenced

SGN-40 (antihuCD40 mAb) monotherapy induces durable objective responses in patients with relapsed aggressive non Hodgkin’s lymphoma: evidence of antitumor activity from a phase I study [abstract

R Advani, A Forero-Torres, RR Furman
Blood • 2006
View 6 Excerpts
Highly Influenced

Epratuzumab, a humanized anti-CD22 antibody, in aggressive non-Hodgkin's lymphoma: phase I/II clinical trial results.

Clinical cancer research : an official journal of the American Association for Cancer Research • 2004
View 7 Excerpts
Highly Influenced

Phase I/II trial of epratuzumab (humanized anti-CD22 antibody) in indolent non-Hodgkin's lymphoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2003
View 7 Excerpts
Highly Influenced

Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2003
View 7 Excerpts
Highly Influenced

Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphoma.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation • 2006

Similar Papers

Loading similar papers…